Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-30
DOI
10.1186/s13046-019-1508-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD44v6 engages in colorectal cancer progression
- (2019) Lixin Ma et al. Cell Death & Disease
- Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway
- (2019) Shuo Fang et al. ONCOGENE
- Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells
- (2018) Jianghong Man et al. Cell Stem Cell
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
- (2018) Ronghua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization
- (2018) Seo-Hyun Choi et al. Nature Communications
- Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer
- (2017) Weiwei Sheng et al. FASEB JOURNAL
- The evolving concept of liver cancer stem cells
- (2017) Kouki Nio et al. Molecular Cancer
- Notch Signaling in Development, Tissue Homeostasis, and Disease
- (2017) Chris Siebel et al. PHYSIOLOGICAL REVIEWS
- Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer
- (2017) Wen-Cheng Chung et al. NEOPLASIA
- Characteristics of liver cancer stem cells and clinical correlations
- (2016) Zhuo Cheng et al. CANCER LETTERS
- Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer
- (2016) M-H Kang et al. ONCOGENE
- Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis
- (2016) Alexander E. Kudinov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MSI2 is required for maintaining activated myelodysplastic syndrome stem cells
- (2016) James Taggart et al. Nature Communications
- Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein
- (2016) Weiwei Sheng et al. Oncotarget
- Musashi Signaling in Stem Cells and Cancer
- (2015) Raymond G. Fox et al. Annual Review of Cell and Developmental Biology
- Musashi2 sustains the mixed-lineage leukemia–driven stem cell regulatory program
- (2015) Sun-Mi Park et al. JOURNAL OF CLINICAL INVESTIGATION
- Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer
- (2015) S Zhang et al. ONCOGENE
- The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma
- (2015) Jing Luo et al. Oncotarget
- Tumor-Suppressive Activity of Lunatic Fringe in Prostate through Differential Modulation of Notch Receptor Activation
- (2015) Shubing Zhang et al. NEOPLASIA
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
- (2014) Jie Ni et al. PROSTATE
- Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1
- (2013) Jia Lu et al. CANCER CELL
- Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition
- (2013) Lu He et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Musashi 2 in hematopoiesis
- (2012) Luisa de Andrés-Aguayo et al. CURRENT OPINION IN HEMATOLOGY
- Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma
- (2012) Zheng-Jun Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Aggressive myeloid leukemia formation is directed by the Musashi 2/Numb pathway
- (2011) Lori N. Griner et al. CANCER BIOLOGY & THERAPY
- New insight into cancer therapeutics: Induction of differentiation by regulating the Musashi/Numb/Notch pathway
- (2010) Yoshinori Nishimoto et al. CELL RESEARCH
- Lunatic fringe potentiates Notch signaling in the developing brain
- (2010) Tomoaki M. Kato et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Regulation of myeloid leukaemia by the cell-fate determinant Musashi
- (2010) Takahiro Ito et al. NATURE
- Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
- (2010) Michael G Kharas et al. NATURE MEDICINE
- Liver Cancer Stem Cells
- (2008) Stewart Sell et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started